{"DataElement":{"publicId":"5581156","version":"1","preferredName":"EORTC QLQ-BLM30 Version 1.0 36 Extent During Past Week Have Unintentional Release of Urine Score 4 Point Scale","preferredDefinition":"Persons' stated perception during the past week of the extent to which they have experienced any unintentional release (leakage) of urine, using a four point Likert scale.","longName":"EORTC_BLM30_36_SCL","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"5573363","version":"1","preferredName":"European Organization for Research and Treatment of Cancer Bladder Cancer Muscle-Invasive 30 Questionnaire Extent During Past Week Have Urinary Incontinence Score","preferredDefinition":"A group with aims to conduct, develop, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients' quality of life. There are more than 60 institutions and departments that have been recognized by EORTC as affiliated. These groups conduct, on a voluntary basis, laboratory research and/or clinical trials on all types of cancers using a multidisciplinary approach. EORTC maintains close working relationship with NCI and the British Cancer Research United Kingdom in London._A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 30 questions designed to assess quality of life in patients with muscle-invasive bladder cancer (BLM)._The range, magnitude, or distance over which a thing spans an interval of distance, space, or time._At some point in a given period of time._The most recent week, including today._A question about the extent to which an individual has or had unintentional release or leakage of urine._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"5573345v1.0:5573361v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"5573345","version":"1","preferredName":"European Organization for Research and Treatment of Cancer Bladder Cancer Muscle-Invasive 30 Questionnaire","preferredDefinition":"A group with aims to conduct, develop, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients' quality of life. There are more than 60 institutions and departments that have been recognized by EORTC as affiliated. These groups conduct, on a voluntary basis, laboratory research and/or clinical trials on all types of cancers using a multidisciplinary approach. EORTC maintains close working relationship with NCI and the British Cancer Research United Kingdom in London.:A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 30 questions designed to assess quality of life in patients with muscle-invasive bladder cancer (BLM).","longName":"C19741:C129791","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for Research and Treatment of Cancer","conceptCode":"C19741","definition":"A group with aims to conduct, develop, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients' quality of life. There are more than 60 institutions and departments that have been recognized by EORTC as affiliated. These groups conduct, on a voluntary basis, laboratory research and/or clinical trials on all types of cancers using a multidisciplinary approach. EORTC maintains close working relationship with NCI and the British Cancer Research United Kingdom in London.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Bladder Cancer Muscle-Invasive 30 Questionnaire","conceptCode":"C129791","definition":"A questionnaire developed by the European Organisation for Research and Treatment of Cancer (EORTC) consisting of 30 questions designed to assess quality of life in patients with muscle-invasive bladder cancer (BLM).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"40FABEE6-4BCA-69F3-E053-F662850AEEC0","latestVersionIndicator":"Yes","beginDate":"2016-11-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-10","modifiedBy":"ONEDATA","dateModified":"2016-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5573361","version":"1","preferredName":"Extent During Past Week Have Urinary Incontinence Score","preferredDefinition":"The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.:At some point in a given period of time.:The most recent week, including today.:A question about the extent to which an individual has or had unintentional release or leakage of urine.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"5573361v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extent","conceptCode":"C25332","definition":"The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"During","conceptCode":"C25490","definition":"At some point in a given period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Past Week","conceptCode":"C95402","definition":"The most recent week. May include the present day.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Degree of Urinary Incontinence","conceptCode":"C129797","definition":"A question about the extent to which an individual has or had unintentional release or leakage of urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"40FB6AA7-9C6C-2EA3-E053-F662850AE40E","latestVersionIndicator":"Yes","beginDate":"2016-11-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-10","modifiedBy":"ONEDATA","dateModified":"2016-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"EORTC QLQ-BLM30:European Organization for Research and Treatment of Cancer Quality of Life Group, Quality of Life Questionnaire-Muscle Invasive Bladder Cancer (BLM30), 1994","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40FB6AA7-9C7D-2EA3-E053-F662850AE40E","latestVersionIndicator":"Yes","beginDate":"2016-11-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-10","modifiedBy":"COOPERM","dateModified":"2016-12-14","changeDescription":"Created for Alliance A031501 study in Rave. mc 11/10/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4728552","version":"1","preferredName":"EORTC Score 4 Point Scale","preferredDefinition":"Numeric scores from 1 (Not at All) to 4 (Very Much) on a Likert scale used on EORTC questionnaires.","longName":"EORTC_4PT_SCL","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":"1","maxLength":"1","minValue":"1","maxValue":"4","decimalPlace":"0","PermissibleValues":[{"value":"2","valueDescription":"A Little","ValueMeaning":{"publicId":"4733151","version":"1","preferredName":"A Little","longName":"4733151","preferredDefinition":"A subjective answer of weak agreement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"A little bit","conceptCode":"C91214","definition":"A subjective answer of weak agreement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107846F3-28A5-D64F-E050-BB89AD433468","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-03-04","modifiedBy":"COOPERM","dateModified":"2018-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"107846F3-28BE-D64F-E050-BB89AD433468","beginDate":"2015-03-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-03-04","modifiedBy":"ONEDATA","dateModified":"2015-03-04","deletedIndicator":"No"},{"value":"1","valueDescription":"Not at all","ValueMeaning":{"publicId":"3144288","version":"1","preferredName":"Not at all","longName":"3144288","preferredDefinition":"A subjective answer of no agreement or ability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not at All","conceptCode":"C91213","definition":"A subjective answer of no agreement or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"917AA83A-DA9B-A8DB-E040-BB89AD43420C","latestVersionIndicator":"Yes","beginDate":"2010-09-30","endDate":null,"createdBy":"UMLLOADER_FACTG","dateCreated":"2010-09-30","modifiedBy":"MAESKEB","dateModified":"2022-04-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"101A0926-922D-6E02-E050-BB89AD435A81","beginDate":"2015-02-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-02-27","modifiedBy":"GDEEN","dateModified":"2023-05-08","deletedIndicator":"No"},{"value":"3","valueDescription":"Quite a bit","ValueMeaning":{"publicId":"2561183","version":"1","preferredName":"Quite a bit","longName":"2561183","preferredDefinition":"A subjective answer describing a fairly large amount or extent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quite a Bit","conceptCode":"C91216","definition":"A subjective answer describing a fairly large amount or extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BC0C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-05-14","endDate":null,"createdBy":"CVALMONT","dateCreated":"2002-05-14","modifiedBy":"KUMMEROA","dateModified":"2022-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"101A0926-923F-6E02-E050-BB89AD435A81","beginDate":"2015-02-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-02-27","modifiedBy":"GDEEN","dateModified":"2023-05-08","deletedIndicator":"No"},{"value":"4","valueDescription":"Very much","ValueMeaning":{"publicId":"3144292","version":"1","preferredName":"Extremely","longName":"3144292v1.00","preferredDefinition":"The highest degree of severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extreme","conceptCode":"C102844","definition":"The highest degree of severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"917AA83A-DB23-A8DB-E040-BB89AD43420C","latestVersionIndicator":"Yes","beginDate":"2010-09-30","endDate":null,"createdBy":"UMLLOADER_FACTG","dateCreated":"2010-09-30","modifiedBy":"MMADDINENI","dateModified":"2022-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"101A0926-9248-6E02-E050-BB89AD435A81","beginDate":"2015-02-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-02-27","modifiedBy":"GDEEN","dateModified":"2023-05-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2452834","version":"1","preferredName":"Scale","preferredDefinition":"an ordered reference standard.","longName":"C25664","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Scale","conceptCode":"C25664","definition":"An ordered reference standard used to measure incremental changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0D51E8D8-69DD-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-02-24","modifiedBy":"ONEDATA","dateModified":"2006-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"EORTC QLQ-C30:European Organization for Research and Treatment of Cancer Quality of Life Group, Questionnaire C30, Version 3. 1995","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"101A0926-9214-6E02-E050-BB89AD435A81","latestVersionIndicator":"Yes","beginDate":"2015-02-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-02-27","modifiedBy":"GDEEN","dateModified":"2023-05-08","changeDescription":"Created for PRO-HRQoL as part of the Round 6 CRF Data Collection Standards. mc 2/27/15; released on 08/17/2015, ylu.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3654497","version":"1","longName":"EORTC QLQ","context":"NCIP","ClassificationSchemeItems":[{"publicId":"5573344","version":"1","longName":"EORTC QLQ-BLM30 Version 1.0","context":"NCIP"}]},{"publicId":"5675693","version":"1","longName":"Quality of Life Measures (Patient Reported Outcomes - Health Related Quality of Life)","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5778773","version":"1","longName":"EORTC QLQ","context":"NCI Standards"},{"publicId":"5881762","version":"1","longName":"EORTC QLQ-BLM30","context":"NCI Standards"}]}],"AlternateNames":[{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"NCIP","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"Have you had any unintentiona","type":"Preferred Question Text","description":"Have you had any unintentional release (leakage) of urine?","url":null,"context":"NCI Standards"},{"name":"EORTC QLQ-BLM30 Version 1.0","type":"Measure Sequence Number","description":"Question #36 of 60","url":null,"context":"NCIP"},{"name":"Using PRO/HRQoL Measures","type":"Outcome Measure Implementation","description":"This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value set in order to retain the validity and reliability associated with the measure. Changes may not be made to these documents. In cases where retaining the question set intact to preserve the validity and reliability are not as important as advancing the science, questions may be used individually or in combination with other measure questions.","url":null,"context":"NCIP"},{"name":"Scoring Manual Link","type":"REFERENCE","description":"The URL citation is provided so that caDSR users can obtain materials related to instructions for administering and/or scoring the measure.","url":"http://groups.eortc.be/qol/bladder-cancer-eortc-qlq-nmibc24-eortc-qlq-blm30","context":"NCIP"}],"origin":"EORTC QLQ-BLM30:European Organization for Research and Treatment of Cancer Quality of Life Group, Quality of Life Questionnaire-Muscle Invasive Bladder Cancer (BLM30), 1994","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"41FBF65C-1344-14B8-E053-F662850AB927","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-23","modifiedBy":"COOPERM","dateModified":"2017-04-21","changeDescription":"Created for Alliance A031501 study in Rave. mc 11/23/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}